Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jie Zha

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Molecular Carcinogenesis|July 22, 2020
Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivoYuanfei Shi, Haijun Zhao, Jing Ye, et al.
European Journal of Pharmacology|April 18, 2021
Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagyJie Zha, Silei Bi, Manman Deng, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling PathwayYuanfang Tang, Mengya Zhong, Guangchao Pan, et al.
BMC Biology|October 13, 2023
Nr4a1 marks a distinctive ILC2 activation subset in the mouse inflammatory lungShasha Xu, Yu Zhang, Xingjie Liu, et al.
Cell Death & Disease|September 19, 2020
Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemiaKai Chen, Qianying Yang, Jie Zha, et al.
Journal of Cancer Research and Clinical Oncology|December 5, 2022
Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signalingGuangchao Pan, Mengya Zhong, Jingwei Yao, et al.
Cell Death & Disease|August 29, 2023
Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemiaChendi Xie, Hui Zhou, Dongmei Qin, et al.
Journal of Hematology & Oncology|August 22, 2022
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometryLong Liu, Xingxing Yu, Zhifeng Li, et al.
Cancer Letters|November 17, 2022
Therapeutic inhibition of PPARα-HIF1α-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemiaHui Zhou, Yuelong Jiang, Yuetin Huang, et al.
Discover Oncology|July 1, 2023
Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathwayJinshui Tan, Mengya Zhong, Yanyan Hu, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Molecular Carcinogenesis|July 22, 2020
Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivoYuanfei Shi, Haijun Zhao, Jing Ye, et al.
European Journal of Pharmacology|April 18, 2021
Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagyJie Zha, Silei Bi, Manman Deng, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling PathwayYuanfang Tang, Mengya Zhong, Guangchao Pan, et al.
BMC Biology|October 13, 2023
Nr4a1 marks a distinctive ILC2 activation subset in the mouse inflammatory lungShasha Xu, Yu Zhang, Xingjie Liu, et al.
Cell Death & Disease|September 19, 2020
Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemiaKai Chen, Qianying Yang, Jie Zha, et al.
Journal of Cancer Research and Clinical Oncology|December 5, 2022
Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signalingGuangchao Pan, Mengya Zhong, Jingwei Yao, et al.
Cell Death & Disease|August 29, 2023
Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemiaChendi Xie, Hui Zhou, Dongmei Qin, et al.
Journal of Hematology & Oncology|August 22, 2022
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometryLong Liu, Xingxing Yu, Zhifeng Li, et al.
Cancer Letters|November 17, 2022
Therapeutic inhibition of PPARα-HIF1α-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemiaHui Zhou, Yuelong Jiang, Yuetin Huang, et al.
Discover Oncology|July 1, 2023
Ritanserin suppresses acute myeloid leukemia by inhibiting DGKα to downregulate phospholipase D and the Jak-Stat/MAPK pathwayJinshui Tan, Mengya Zhong, Yanyan Hu, et al.
Pageof 9